Cargando…

Current status, problems, and perspectives of non-alcoholic fatty liver disease research

Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease that can lead to liver cirrhosis, liver cancer, and ultimately death. NAFLD is pathologically classified as non-alcoholic fatty liver (NAFL) or non-alcoholic steatohepatitis (NASH) based on the existence of ballooned hepatocy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Naoki, Kimura, Takefumi, Fujimori, Naoyuki, Nagaya, Tadanobu, Komatsu, Michiharu, Tanaka, Eiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337019/ https://www.ncbi.nlm.nih.gov/pubmed/30670907 http://dx.doi.org/10.3748/wjg.v25.i2.163

Ejemplares similares

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
por: Kimura, Takefumi, et al.
Publicado: (2018)

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018)

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
por: Nagaya, Tadanobu, et al.
Publicado: (2015)

Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy
por: Tanaka, Naoki, et al.
Publicado: (2020)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis
por: Sekiguchi, Tomohiro, et al.
Publicado: (2015)

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
por: Saito, Hiromi, et al.
Publicado: (2018)

Citrin Deficiency: Clinical and Nutritional Features
por: Komatsu, Michiharu, et al.
Publicado: (2023)

Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease
por: Shibata, Soichiro, et al.
Publicado: (2016)

Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease
por: Kimura, Takefumi, et al.
Publicado: (2021)

Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2017)

Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
por: Umemura, Takeji, et al.
Publicado: (2014)

STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
por: Joshita, Satoru, et al.
Publicado: (2014)

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan
por: Nozawa, Yuichi, et al.
Publicado: (2013)

Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies
por: Jia, Fangping, et al.
Publicado: (2021)

Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
por: Di Sessa, Anna, et al.
Publicado: (2019)

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2018)

Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study
por: Okumura, Taiki, et al.
Publicado: (2023)

Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
por: Lau, Jennie Ka Ching, et al.
Publicado: (2016)

Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
por: Kjærgaard, Kristoffer, et al.
Publicado: (2021)

Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors
por: Yamakado, Minoru, et al.
Publicado: (2017)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
por: Vajro, Pietro, et al.
Publicado: (2012)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives
por: Drapkina, Oxana M., et al.
Publicado: (2023)

Current treatment of non‐alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: the pathologist’s perspective
por: Leow, Wei-Qiang, et al.
Publicado: (2023)

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
por: Sugiura, Ayumi, et al.
Publicado: (2017)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis
por: Athinarayanan, Shaminie, et al.
Publicado: (2012)

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
por: Nevola, Riccardo, et al.
Publicado: (2023)

Fatty Acid Accumulation and Resulting PPARα Activation in Fibroblasts due to Trifunctional Protein Deficiency
por: Wakabayashi, Masato, et al.
Publicado: (2012)

Small Bowel Tissue Concentration of Rebamipide: Study of Two Dosages in Healthy Subjects
por: Akamatsu, Taiji, et al.
Publicado: (2010)

Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome
por: Sogabe, Masahiro, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease–From the cardiologist perspective
por: Sîrbu, Oana, et al.
Publicado: (2016)

Current status of imaging in nonalcoholic fatty liver disease
por: Li, Qian, et al.
Publicado: (2018)

Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis
por: Yabe, Yoshito, et al.
Publicado: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
por: Berardo, Clarissa, et al.
Publicado: (2020)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

Splenic artery pseudoaneurysm resulting from gastric ulcer presenting acute upper gastrointestinal bleeding
por: Okumura, Taiki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vvlljalffb2ek19b10fe3s6fk7